Stress Granules: Generalities
=============================

Stress granule (SG) formation is a pan-cellular mechanism employed to counter exposures to osmotic ([@B41]; [@B26]), oxidative ([@B57]; [@B104]; [@B79]), mitochondrial ([@B103]; [@B18]), or endoplasmic reticulum (ER) stress ([@B59]; [@B40]), viral infection ([@B28]; [@B96]), proteasome inhibition ([@B77]; [@B19]; [@B33]), inhibition of translation initiation ([@B25]; [@B78]), ultraviolet light ([@B64]; [@B95]), cadmium chloride ([@B16]) as well as certain anti-cancer ([@B69]; [@B78]; [@B36]) and antifungal drugs ([@B86]; [@B13]), (**Figure [1A](#F1){ref-type="fig"}**). An analysis of 154 reports published between 1999 and 2014 reveals that the majority of our knowledge of these cytoplasmic foci derives from studies in HeLa cells (45%) using sodium arsenite (SA) as a means of oxidative stress (63%) or thermal stress (33%; **Figure [1B](#F1){ref-type="fig"}**). It is noteworthy that not all environmental conditions induce a SG response. Namely, inhibition of RNA polymerase, exposure to inflammatory cytokines, nutrient depletion, and destabilization of microtubules and/or actin microfilaments do not induce SG formation in mammalian cells ([@B57]).

![**Cell lines and stress inducing agents used in stress granule studies.** Analysis of 154 articles published between 1999 and 2014. Some publications used many cells type and/or many stresses. **(A)** Stresses involved in stress granule (SG) studies. **(B)** Cell lines used in SG studies.](fncel-09-00423-g001){#F1}

Stress granules were first defined as cytoplasmic foci containing polyadenylated RNA, small ribosomal sub-units, translation initiation factors (eIF3, eIF4E, eIF4G), and RNA binding proteins (RBPs) such as TIA-1, HuR, PABP, and TTP that formed following eIF2α phosphorylation. Furthermore, SGs formed from numerous small inclusions that fused over time and dissolved once the stress abated, and were inhibited by cycloheximide treatment ([@B57]). This definition still applies today, but the number and variety of proteins reported as recruited to SGs has exploded.

Stress granules are distinct from other RNA granule inclusions called Processing Bodies (PBs), even though they share some common protein components under certain conditions ([@B56]; [@B25]; [@B68]; [@B116]). PBs do not contain initiation elongation factors, with the exception of some eIF4 subunits ([@B56]; [@B107]). PBs contain proteins involved in translational repression and mRNA degradation ([@B90]; [@B62]) and are present in basal conditions but can also be induced by some stress exposures ([@B101]; [@B56]). For example, SA induces both structures while heat shock or clotrimazole induce only SGs ([@B56]). PB formation is dependent on available mRNA in the cytoplasm ([@B56]; [@B107]; [@B90]), and is independent of eIF2α phosphorylation ([@B56]). SGs and PBs can also interact in a process referred to as "docking" ([@B56]; [@B90]; [@B7]). How SGs and PBs function together in the stress response is expected to be at the center of future important discoveries.

Protein Composition of Stress Granules
--------------------------------------

Stress granules are extremely labile inclusions, non-limited by membranes ([@B85]; [@B54], [@B56]; [@B52]; [@B15]). Many of the RBPs found in SGs contain low complexity domains which are prone to aggregation. These multimeric protein assemblies are neither soluble nor insoluble but proposed to be in an intermediate labile state referred to as a "hydrogel". This unique feature permits SGs to be highly dynamic and in constant exchange with cytoplasmic components ([@B43]; [@B51]). It is for this reason that there is no published biochemical method to purify SGs so that their composition and function may be more deeply interrogated. In our analysis of SG-related publications (1999--2014), the majority of the proteins described as localized to SGs belong to the large family of RBPs (60%). A similar proportion are implicated in RNA metabolism including transcription (12%), splicing (8%), RNA transport (7%), degradation (4%), silencing (2%), mRNA stabilization (3%), and translation (12%). There are also helicases (4%) and small ribosomal proteins (5%). Of the remaining 40% of SG-recruited proteins not involved in RNA metabolism, 11% have a role in post-translational modification, 9% participate in cell organization/protein transport, 4% in nuclear import, 3% are (co)-chaperones, and 13% are sufficiently diverse to be classified as other (**Figure [2](#F2){ref-type="fig"}**; Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). These descriptors have led to the proposal that SGs might also serve to integrate complex cellular signaling ([@B55]).

![**Stress granule composition.** Analysis of 154 publications between 1999 and 2014. **(A)** Cellular metabolism functions of proteins recruited to SGs. **(B)** Specific function in mRNA metabolism of proteins recruited to SGs.](fncel-09-00423-g002){#F2}

Stress granules contain translation initiation factors eIF3, eIF4, eIF5 (Elongation Initiation Factor 3--5; [@B53]; [@B70]), small ribosomal subunits (S3, S6, S18, S19; [@B53]; [@B59]; [@B30]), and numerous RBPs. Among the latter group, TIA-1 (T-cell-restricted intracellular antigen-1) and G3BP1 (Ras GAP SH3 domain-binding protein 1) are the two most commonly studied and utilized SG markers ([@B57]; [@B108]; [@B39]). The overexpression of either of these proteins is sufficient to drive the formation of cytoplasmic inclusions, often referred to as "spontaneous" or "constitutive" SGs ([@B108]; [@B39]; [@B97]). Both TIA-1 and G3BP1 feature a glycine-rich domain, also known as a prion-like, low complexity or intrinsically disordered domain, which facilitates the first step of SG formation ([@B52]; [@B108]; [@B39]). Historically, TIA-1 was the most frequently studied marker of SGs, but has now been surpassed by G3BP1 in the literature.

G3BP1 was first described as a nuclear mRNA binding protein preferentially expressed in the brain ([@B89]; [@B75]). It is implicated in mRNA degradation via its endoribonuclease activity induced by its phosphorylation at Ser^149^ ([@B38]; [@B109]). Coincidentally, Ser^149^ phosphorylation inhibits SG formation ([@B108]). That G3BP1 is central to SG dynamics is supported by the observation that G3BP1 function is often circumvented during viral infections. Most strikingly, during poliovirus infection, G3BP1 is cleaved by the viral protease 3C. Consequently, infected cells exposed to heat shock have disrupted SG dynamics such that SG size is diminished compared to non-infected heat-shocked cells ([@B117]; [@B93]). In primary embryonic fibroblasts derived from these G3BP1^-/-^ mice, when SGs are able to form, they are less numerous, smaller and less well-defined ([@B48]). It is noteworthy to mention that G3BP1 is a neuronal survival factor since G3BP1-null mice die in the neonatal phase owing to wide-spread neuronal cell death within the central nervous system within 15 min of being *ex utero* ([@B119]). A second G3BP1-null model was created that generates viable pups but demonstrates clearly that G3BP1 is critical for synaptic plasticity and calcium homeostasis, establishing a link between SGs and neurodegeneration ([@B75]). Taken together, these data indicate that G3BP1 is an essential component regulating SG dynamics and is relevant to neurons. G3BP2, a close homolog of G3BP1, is also recruited to SGs and has been suggested to partially compensate for the loss of G3BP1 ([@B61]; [@B76]). However, it has been recently demonstrated that while G3BP1 is necessary for SG secondary aggregation and SG function, G3BP2 is dispensable for these aspects, although simultaneous down-regulation of both abrogates SG formation ([@B7]). Further studies are needed to clearly define the role of G3BP2 in SGs.

Stress Response in Neurodegenerative Diseases
---------------------------------------------

Neurodegenerative diseases are often characterized by pathological inclusions, a subset of which colocalize with SG markers. For example, TIA-1 co-localizes with neuronal inclusions formed in response to expression of the first exon of the *Huntingtin* gene containing a polyglutamine expansion (a well described model for Huntington disease; [@B114]). In two different mouse models of Alzheimer's disease expressing Tau, three different cytoplasmic inclusions containing TIA-1, G3BP1, or TTP (Tristetraprolin, an RBP recruited to SGs) are observed. The presence and the size of all of those inclusions correlate with disease severity ([@B112]). TIA-1 and TTP colocalize with phosphorylated Tau inclusions in murine models and in post-mortem patient tissues primarily at later disease stages. In contrast, G3BP1 inclusions have weak immunoreactivity for pathological Tau (marked by PHF-1 antibody) at any stage. Interestingly, although TDP-43 (TAR DNA binding protein 43) cytoplasmic inclusions were also observed in animals with moderate to severe pathology, they did not co-label with TIA-1 or PHF-1 ([@B112]).

In contrast, in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), subsets of TDP-43 containing cytoplasmic inclusions label for SG markers such as TIA-1, eIF3 and PABP (Polyadenylate-binding protein; [@B113]; [@B27]; [@B73]; [@B13]; [@B80]), (**Table [1](#T1){ref-type="table"}**). It has been proposed that the formation of these pathological inclusions may be due to misregulation of the SG response. Indeed, one of the most prevalent hypotheses is that inclusion formation is driven by the failure of SGs to disassemble. At present, there is no data nor methodology available to determine if these inclusions are broadly composed of SG proteins or if SG proteins are themselves recruited to pre-formed inclusions ([@B12]).

###### 

Stress granule markers observed in pathological amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) inclusions.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------
  ALS protein   SG markers             Processing Bodies (PB) markers   Patients                         Tissue                      Reference        
  ------------- ---------------------- -------------------------------- -------------------------------- --------------------------- ---------------- ---------
  TDP-43                               TIA-1, HuR                                                        3 Sporadic ALS              Spinal cord      [@B19]

  TDP-43        TIA-1                                                                                    Sporadic ALS                                 [@B113]

                                                                        XRN1, not frequent                                                            

  FUS           PABP1, eIF4G                                                                             1 Familial ALS-FUS^R521C^   Spinal cord      [@B27]

                                                                                                         7 Sporadic FTD-FUS          Hippocampus      

  TDP-43                               PABP1, eIF4G                                                      2 Sporadic FTD-TDP                           

  TDP-43        eIF3, TIA-1                                             Negative for Dcp1A (not shown)   ALS\                        Spinal cord\     [@B73]
                                                                                                         FTD                         Frontal cortex   

  TDP-43        PABP1 (66% of cases)                                                                     ALS-TDP                     Spinal cord      [@B13]

                                       PABP1                                                             FTD-TDP                     Hippocampus      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------

Pathological Inclusions in ALS/FTD
----------------------------------

Ubiquitin-positive inclusions are primarily observed in neurons and sometimes glial cells of ALS and FTD post-mortem tissues from the central nervous system ([@B6]; [@B84]; [@B72]). They typically contain one of two RBPs known to also harbor disease-causing mutations, TDP-43 or FUS (Fused in liposarcoma; [@B19]; [@B113]; [@B27]; [@B73]; [@B13]). TDP-43 is a major resident of these pathological inclusions being detected in 97% of all ALS cases and 45% for FTD. In contrast, FUS-immunoreactive inclusions are found in only 2% of ALS and 9% of FTD cases ([@B6]; [@B84]; [@B72]). The functional significance of these structures remains poorly defined and several possibilities have arisen. First, inclusions could be indirectly harmful due to inappropriate sequestration of critical cellular signaling proteins. Second, the pathological process or mutations could induce protein misfolding, so as to affect cell signaling and enhance cell vulnerability. On the other hand, inclusions could also be considered as neuroprotective due to sequestration of misfolded protein. Lastly, inclusions could be inert and have no direct link to or bearing on disease pathogenesis. Which of these scenarios is correct is still not yet understood and a major focus of the field ([@B6]; [@B84]; [@B49]; [@B102]; [@B63]; [@B110]; [@B72]).

From Inclusions to Stress Granules?
-----------------------------------

The presence of SG markers within TDP-43 positive inclusions has led to the hypothesis that pathological TDP-43/FUS containing inclusions originate from SGs that have failed to disassemble. While TDP-43 and FUS inclusions have been reported to clearly co-localize with some specific SG markers, it is not a universal finding for both proteins ([@B19]; [@B113]; [@B27]; [@B73]; [@B13]), (**Table [1](#T1){ref-type="table"}**). In addition, these studies should perhaps be interpreted with some measure of caution since some of the SG markers used in these studies, including TIA-1 and HuR, are reported to label other RNA granule subtypes (such as PBs) in certain contexts ([@B25]; [@B69]). In our view, the question remains very much open as to whether inclusions derive from SGs.

A number of proteins linked to ALS are found in SGs and/or patient inclusions leading to the proposal that mutant disease proteins may interfere in the normal SG response during pathogenesis. These include VCP (Valosin-containing protein; [@B1]; [@B17]; [@B100]), SMN (Survival of motor neuron; [@B44]; [@B92]), hnRNP A1 and hnRNP A2 (Heterogeneous nuclear ribonucleoprotein A1 and A2; [@B79]; [@B58]), TAF15 (TATA-binding protein-associated factor 15; [@B5]; [@B21]), Angiogenin ([@B42]; [@B20]; [@B29]) and Profilin1 ([@B118]; [@B32]). However, generally the focus is on TDP-43 and FUS ([@B5]; [@B19]; [@B15]; [@B34]; [@B73]; [@B26]; [@B79]; [@B13]). TDP-43 and FUS share many structural similarities (**Figure [3](#F3){ref-type="fig"}**) and both are involved in various aspects of mRNA metabolism including splicing, nucleocytoplasmic shuttling, transcription, mRNA stability, and SG dynamics ([@B65]). Specifically, they both have prion-like domains ([@B22]; [@B60]; [@B71]), and the combination of a prion-like domain and a RRM has recently been used to predict genetic modifiers or causes of several neurodegenerative diseases ([@B60]). Thus, it has been proposed that these two proteins may participate in a common pathogenic mechanism. In ALS, exposure to external stress is frequently proposed as a contributor to either disease initiation or rate of progression ([@B24]). Given that TDP-43 and FUS are both recruited to SGs and modulate the SG response (see below), it is reasonable to propose that they may serve as an interface between genetic susceptibility and environmental stress exposure in disease pathogenesis. This thus explains the intensifying interest around these molecules and their involvement in the SG response.

![**TDP-43 and FUS protein structures.** FUS and TDP-43 have structural similarities with both harboring a Prion-like domain, RNA recognition motif(s), nuclear localization signal, and nuclear export signal. Details regarding the position of domains were derived from UniProt.](fncel-09-00423-g003){#F3}

Localization Of TDP-43 and FUS to Stress Granules
=================================================

Between 2010 and 2012, five different teams evaluated the link between TDP-43 and SGs. All used different cell lines, different stress-inducing agents, and different SG markers. From this collective work, it is now recognized that TDP-43 is recruited to SGs following a range of stress stimuli including ER, osmotic, oxidative, thermal, and mitochondrial stress as well as proteasome inhibition. While all of these studies used different markers, there is consensus that TDP-43 is recruited uniquely to SGs and not PBs (**Table [2](#T2){ref-type="table"}**). Localization of TDP-43 to SGs is mediated by both its RRM1 domain as well as its C-terminal glycine-rich/prion-like domain ([@B19]; [@B26]). These data imply that the binding of TDP-43 to mRNA via its RRM1 as well as proteins, via the C-terminus, is relevant to its SG localization. Using transient overexpression of TDP-43, only one team has reported that exogenous TDP-43 induces the formation of "constitutive SGs" ([@B73]). These results are reminiscent of what is observed following high-level overexpression of TIA-1 and G3BP1 and thus may reflect the consequence of supra-expression of aggregation-prone proteins which feature a prion-like domain ([@B57]; [@B108]). Moreover, other groups do not observe these TDP-43 induced structures ([@B19]; [@B26]; [@B115]). While this discrepancy remains to be resolved, whether cytoplasmic aggregates induced by TDP-43, TIA-1, or G3BP1 overexpression satisfy the consensus definition of SGs also remains to be determined.

###### 

TDP-43 localization to SGs.

  Cell type       Stress                      SG markers                     TDP-43 visualization          Reference        
  --------------- --------------------------- ------------------------------ ----------------------------- ---------------- --------
  HEK293T         0.4 M sorbitol, 1 h         HuR, hnRNPA1, TIAR             Overexpression + Endogenous   [@B26]           
  Cortical glia                                                                                                             
  BE-M17          HEK293                      0.5 mM SA, 1 h                 TIA-1, TIAR, PABP, eIF3       Overexpression   [@B73]
                                              Hanks balanced salt solution                                                  
  NSC34           0.5 mM SA, 30 min           TIA-1, HuR                     Overexpression + Endogenous   [@B19]           
                  Heat shock, 44°C, 30 min                                                                                  
                  10 μM MG132, 4 h                                                                                          
  SK-N-SH         0.5 mM SA, 30 min           TIA-1                          Endogenous                    [@B79]           
  HeLa            0.5 mM SA, 30 min                                                                                         
                  Heat shock, 43°C, 30 min                                                                                  
                  1 μM thapsigargin, 50 min                                                                                 

Exogenously expressed mutant FUS is recruited to SGs in response to oxidative, thermal, mitochondrial and ER stress ([@B5]; [@B15]; [@B13]; [@B23]), (**Table [3](#T3){ref-type="table"}**). Interestingly, while GFP-FUS^WT^ is recruited to less than 10% of TIAR-positive SGs ([@B5]; [@B13]), SG localization is exacerbated when FUS is mutated ([@B15]; [@B9]; [@B67]). In contrast, endogenous FUS is reported to robustly localize to SGs only in conditions of hyperosmolarity ([@B99]) and does not colocalize with the PB marker GE-1/HEDLS ([@B15]). Localization of FUS to SGs is independent of its glycine-rich/prion-like domain but does require its capacity to bind mRNA ([@B5]; [@B13]; [@B23]). Mutations in FUS frequently disrupt the nuclear localization sequence (NLS), thereby leading to an accumulation of FUS in the cytoplasm that contributes to its increased recruitment to SGs ([@B111]). Intriguingly, mutant FUS localized to SGs will further recruit wild type FUS protein ([@B111]). Lastly, overexpression of FUS (wild type or mutant) itself does not induce "constitutive SGs" but rather requires a stress stimulus to trigger SG localization ([@B15]; [@B23]).

###### 

FUS localization to SGs.

  Cell types                                     Stress conditions            SG markers                                        FUS visualization                                Reference
  -------------- ------------------------------- ---------------------------- ------------------------------------------------- ------------------------------------------------ -----------
  HeLa           HT-1080                         0.5 mM SA, 1 h               TIA-1                                             Endogenous and overexpressed wild type protein   [@B5]
                                                 Heat shock, 44°C, 1h                                                                                                            
  SH-SY5Y        primary hippocampal neurons     Heat shock, 44°C, 1h         TIA-1                                             Overexpression of mutant proteins                [@B13]
                                                 0.5 mM SA, 30 min                                                                                                               
                                                 20 μM clotrimazole, 30 min                                                                                                      
  HEK293         0.5 mM SA, 1 h                  TIAR                         Overexpression of mutant and wild type proteins   [@B15]                                           
                 10 μM thapsigargin, 2 h                                                                                                                                         
                 Heat shock 42.5°C, 30 min                                                                                                                                       
  fish embryos   Heat shock 42.5°C, 45 min                                                                                                                                       
  HeLa           0.4 M sorbitol, 20 min or 1 h   G3BP, TIAR                   Endogenous wild type protein                      [@B99]                                           

The Role of Endogenous TDP-43 and FUS in Stress Granule Dynamics
----------------------------------------------------------------

While many teams have analyzed the effect of mutant or wild type proteins on SG phenotypes using overexpression in a range of transformed cell lines ([@B73]; [@B26]; [@B9]; [@B115]), there are only a handful that have examined the role of the endogenous proteins in SG dynamics ([@B19]; [@B79]; [@B8], [@B7]; [@B14]). Importantly, decreasing the expression of either TDP-43 or FUS does not abolish SG formation ([@B19]; [@B73]; [@B79]; [@B8]; [@B14]; [@B99]). In response to arsenite-induced oxidative stress, TDP-43 depletion does not influence eIF2α phosphorylation ([@B79]). However, SG dynamics are affected at several levels such that SG assembly is delayed, secondary aggregation is abrogated and disassembly is accelerated ([@B79]). The SG proteins G3BP1 and TIA-1 are down and up-regulated, respectively, in cells depleted of TDP-43 ([@B79]). In addition, at early time points, SGs have a diffuse and more irregular morphology ([@B79]). This latter observation prompted a deeper investigation of how TDP-43 influences the assembly process. Normally, SGs form initially as multiple small cytoplasmic puncta, which gradually coalesce into larger and less numerous structures. This process, sometimes referred to as secondary aggregation, is completely abolished when TDP-43 levels are reduced ([@B8]). The significance of this two-step assembly of SGs has been enigmatic. However, it has recently been uncovered that SG coalescence (i.e. larger SGs) favors interactions with PBs. Indeed, this interaction seems to be essential to the protection of polyadenylated mRNA during oxidative stress. Interestingly, cells depleted of G3BP1 have very similar disturbances in SG assembly and disassembly ([@B7]). Furthermore, reintroduction of G3BP1 in TDP-43 depleted cells fully rescues SG secondary aggregation, PB docking, and mRNA protection ([@B8], [@B7]). Thus, endogenous TDP-43 regulates the primary effector of SG secondary aggregation and function, G3BP1 ([@B8], [@B7]). Intriguingly, neuronal-like cells exposed to oxidative stress demonstrated a greater vulnerability than non-neuronal cells, an effect which correlates with TDP-43 mediated regulation of G3BP1 ([@B8]). The mechanism by which TDP-43 regulates G3BP1 remains unknown.

In contrast, depletion of FUS does not interfere with SG assembly ([@B8]; [@B14]; [@B99]). SGs form at the same rate in cells depleted of endogenous FUS compared to cells treated with control siRNA, and secondary aggregation proceeds normally ([@B8]). Consistent with this, SG-PB docking, mRNA preservation, and cell survival is undisturbed in FUS-depleted cells following oxidative stress ([@B8], [@B7]). The role for FUS in SG disassembly is unknown. Thus, although TDP-43 and FUS are considered to be closely related, they have very divergent endogenous roles in the regulation of SG dynamics.

Influence of TDP-43 and FUS Mutations on Stress Granule Dynamics
----------------------------------------------------------------

Whether disease-associated mutations in TDP-43 or FUS result in a gain or loss of function with respect to the role of these proteins in SG dynamics remains unresolved. Expression of ALS-linked mutations in TDP-43 is reported to increase both the number of SGs per cell and the size of individual SGs compared to cells transfected with TDP-43^WT^ ([@B73]; [@B26]). Unfortunately, these studies do not include an analysis of untransfected cells, making it difficult to determine the impact of TDP-43 overexpression itself on SG dynamics. Notably, overexpression of TDP-43^WT^ induces cell death ([@B73]). Interestingly, mutant TDP-43 expression induces an equivalent amount of cell death in basal conditions. However, stress exposure exacerbates cell death uniquely in cells overexpressing mutant forms of TDP-43 ([@B73]). This latter result is reminiscent of that which is observed in the context of TDP-43 depletion ([@B8]).

For FUS, the story is once again divergent. First, wild type FUS protein, both endogenous and overexpressed, localizes to SGs in response to osmotic stress but does not show a robust localization in response to oxidative, thermal or ER stress ([@B5]; [@B15]; [@B9]; [@B99]; [@B67]). However, mutant FUS expression increases the number of cells forming SGs in response to oxidative stress ([@B15]). Arsenite-induced SGs in cells expressing the predominantly cytoplasmic mutant FUS^R495X^ are larger and modestly more abundant compared to cells expressing FUS^WT^. Moreover, SG assembly is delayed and disassembly is accelerated ([@B9]; [@B67]). Even though SGs are larger in FUS^R495X^ expressing cells, the dynamic exchange of TIA-1 and G3BP1 between SGs and the cytoplasm is faster compared to cells expressing FUS^WT^ ([@B9]). Thus, in the presence of mutant FUS, SG protein interactions are more labile and likely explain the observed defects in assembly and disassembly ([@B9]).

Microtubule-based Transport in SG Dynamics: Links to ALS?
---------------------------------------------------------

Microtubule-based transport defects are observed in several ALS models ([@B105]; [@B37]) and thus are suggested to be relevant to ALS pathogenesis. Microtubule-directed movements are implicated in SG formation with depletion of proteins involved in microtubule-mediated transport affecting both SGs and PBs ([@B3]; [@B2]; [@B86]; [@B74]; [@B10]). In addition, microtubule destabilization leads not only to defective secondary aggregation of SGs and accelerated disassembly ([@B82]; [@B47]), but also increased PB formation ([@B11]; [@B106]; [@B3]; [@B2]). These same phenotypes are observed in cells depleted of TDP-43 or G3BP1. However, depletion of endogenous TDP-43 or G3BP1 is not reported to be associated with obvious alterations in the microtubule network.

Microtubule-based transport requires not only the "cytoskeletal highway" but also motor and adaptor proteins. Analysis of published data reporting on transcripts bound by TDP-43 reveals several Kinesin family members and Kinesin binding proteins (Kcl1, Kifap3, Kif3c, Kif3a, Kif5a, Kif5c, Trak1, Trak2) as well as three Dynein family members (DynII2, Dync1li2, BicD1; [@B94]). While the axonal transport of mutant TDP-43 containing RNA granules is disrupted ([@B4]), the mechanism by which this occurs remains unknown. It is tempting to speculate that TDP-43 regulates the expression of these proteins, and thus influences microtubule-based transport, but this remains untested. In the context of microtubule-directed SG dynamics, TDP-43 regulates both G3BP1 and HDAC6, which together are reported to bridge the interaction between SGs and motor proteins ([@B64]; [@B31]; [@B79]). Thus, microtubule-based transport could still be relevant to the overall coordination of SG dynamics influenced by TDP-43.

The involvement of FUS in cellular movement is less studied compared to TDP-43. However, in a recent summary of FUS splicing targets, three genes reported in at least two independent studies include the actin binding protein ENAH (Protein enabled homolog), EPB4.1L2 (Band 4.1-like protein 2), and EPB4.9 (Dematin; [@B45], [@B46]; [@B66]; [@B98]; [@B83]; [@B88]). While the role of FUS in actin-based transport has been confirmed ([@B35]), actin-based transport is reported as not involved in SG movement ([@B82]). Interestingly, FUS has been previously observed in RNA granules transported in a microtubule-dependent manner and as a binding partner of kinesin ([@B50]). However, whether FUS (wild type or mutant forms) can influence microtubule-based transport remains unknown.

Unlinking Stress Granules and Pathological TDP-43 and FUS Inclusions
====================================================================

As described above, TDP-43 cytoplasmic inclusions are independent of inclusions marked by SG markers in AD model mice ([@B112]). However, in ALS/FTD human samples, there are a handful of examples of co-labeling of TDP-43 and FUS inclusions with well-known SG markers ([@B19]; [@B113]; [@B27]; [@B73]; [@B13]). Despite the many papers documenting TDP-43 positive inclusions in patient tissues, there is little known about their origins, with only a single team reporting the generation of "stable" TDP-43 positive inclusions that are distinct from SGs in cultured cells ([@B81]; [@B91]). That these inclusions are distinct from SGs is possibly in the details since the experimental conditions are quite different from those generally used to examine TDP-43 in SGs. Specifically, cells were exposed to a stress stimulus over a prolonged period of time (1 mM paraquat, 24 h) rather than the intense acute stress that is more typically used in SG studies (0.1--0.5 mM SA, 30--60 min or 42°C heat shock, 30--60 min). Interestingly, this paraquat model recapitulates the main features observed in ALS/FTD tissues, namely the nuclear clearance and cytoplasmic aggregation of TDP-43 ([@B81]; [@B91]). While the authors initially claim that the observed inclusions are SGs based on co-localization with HuR and TIAR, it is noted that two types of inclusions are actually formed by paraquat exposure. One subset is positive for TDP-43 while a second subset demonstrates robust HuR labeling. Importantly, these two types of inclusions do not share the same kinetic properties. Namely, HuR positive inclusions are cycloheximide-sensitive and disassemble once the stress is removed, consistent with a SG identity ([@B91]). However, TDP-43 positive inclusions persist in the presence of cycloheximide and after removal of paraquat, suggesting that these structures are likely not SGs according to the definition broadly accepted by the field ([@B57]; [@B91]). Thus, even though this stress paradigm induces TDP-43 positive inclusions, it cannot be asserted that they are truly SGs. This could be considered as *in vitro* evidence that TDP-43 pathological inclusions are distinct from SGs. Unfortunately, the functional significance of these inclusions on cell survival/vulnerability remains unknown. Similarly, the impact of FUS and its ALS-linked mutations remains to be explored. Despite these shortcomings, this paraquat model is intriguing since it mimics ALS/FTD pathology and thus may be ideally suited to further investigate whether a pathogenic link between SGs and TDP-43/FUS positive inclusions does in fact exist.

Similarities Between TDP-43 and FUS
===================================

Most studies on TDP-43 and FUS and SGs have investigated the "toxic gain of function" aspect of these two proteins containing ALS-linked mutations. However, surprisingly, even though the impact on assembly is well described, SG disassembly is typically ignored and the link between mutations and cell sensitivity to stress is often unexplored. In contrast, there are robust correlations between defective SG kinetics and cell vulnerability post-stress in "loss of function" models for TDP-43 that are not shared by FUS ([@B8], [@B7]). However, there are some similar alterations in SG dynamics induced by depletion of endogenous TDP-43 and overexpression of mutant FUS (**Figure [4](#F4){ref-type="fig"}**). Specifically, in both contexts, cells exhibit delayed SG formation and accelerated SG resolution ([@B79]; [@B9]). Interestingly, mutant FUS expression gives rise to increased SG size which could be attributed to increased lability of TIA-1 and G3BP1 in SGs ([@B9]). Specifically, this property may result in faster disassembly due to inefficient packing/formation of individual SGs, effectively yielding larger yet less stable structures. Since there is no evidence that FUS impacts SG function and assembly, we propose that FUS mutations primarily impact SG dynamics via a gain of function mechanism. In contrast, while expression of mutant TDP-43 increases SG size, nothing is known about SG disassembly in this context, but the notion that larger SGs are more labile and thus disassemble faster, as is the case for FUS, is possible. However, TDP-43 loss of function (depletion by siRNA) induces the down-regulation of the major SG regulator G3BP1 ([@B79]) which is linked to increased susceptibility of neuronal-like cells to oxidative stress ([@B8]). More in-depth studies examining the impact of mutant TDP-43 on SG kinetics and G3BP1 expression/post-translational modification and/or lability in SGs are needed as is investigation of nuclear clearance of TDP-43 in the context of SGs.

![**Down-regulation of TDP-43 and expression of mutant FUS share SG phenotypes.** Delayed SG assembly and faster SG disassembly is observed in cells with reduced levels of TDP-43 as well as cells expressing mutant forms of FUS. This phenotype increases cell vulnerability. Cells reduced in TDP-43 levels will present a defect in SG secondary aggregation concomitant with a decrease in SG/PB docking followed by an increase in mRNA degradation after stress (siTDP-43 cells compared to siControl cells). This effect is mediated via G3BP1. Cells expressing mutant forms of FUS form larger SGs with more labile TIA-1 and G3BP1 protein compared to cells transfected with FUS^WT^.](fncel-09-00423-g004){#F4}

The origin and nature of pathological inclusions found in ALS/FTD patients remains poorly understood. Inclusion formation could be a mechanism by which the neuron sequesters non-functional protein that could otherwise perturb normal function. Alternatively, they could arise from defective removal of normal SGs, themselves a type of cytoplasmic aggregate, responding to cellular stress. Lastly, it is remains equally possible that inefficient clearance of non-specific aggregates composed of non-functional proteins which feature aggregation-prone domains could yield these cytoplasmic accumulations or "primo-aggregates" of undefined composition. This is an interesting concept given the discovery of VCP-mediated autophagy as a mechanism to clear SGs post-heat shock ([@B17]). However, the role of VCP remains unclear given that oxidative stress or proteasome inhibition of VCP-depleted cells feature smaller SGs with atypical composition ([@B100]).

Conclusion
==========

In recent years, there has been an important increase in the novel descriptions of proteins localizing to SGs using co-localization with only one or two previously reported SG markers. However, according to the original definition of SGs, the co-localization with protein markers is not sufficient to qualify a cytoplasmic inclusion as a SG ([@B57]). Indeed, a large proportion of SG proteins contain a prion-like/unstructured/low complexity domain ([@B71]) that could drive proteins aggregation in a non-specific way ([@B87]). TDP-43 and FUS most definitely have a role in the stress response via their involvement in SGs and by interacting with proteins localizing to SGs ([@B34]). However, determining the link between their involvement in SG dynamics/function and the formation of pathological inclusions is still very much unclear. Whether TDP-43 or FUS recruitment to pathological inclusions drives inclusion formation or they are passively incorporated via a non-specific mechanism is an important future direction. Hand in hand with this, elucidating whether these cytoplasmic inclusions are beneficial, toxic or irrelevant is of utmost importance.
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